相关实验视频
Updated: May 31, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.1K
在喘中准警示素:从银行到诊所
Ayobami Akenroye1, Joshua A Boyce2, Hirohito Kita3
1Jeff and Penny Vinik Immunology Center, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass.
The Journal of allergy and clinical immunology
|January 24, 2025
概括
针对警示素的新喘疗法为各种患者群体提供精准医学. 这种方法解决了当前治疗方法的局限性,改善了T2高和T2低喘的护理.
科学领域:
- 免疫学和过敏学
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 超过20年的机制研究已经为中度至重度喘提供了针对IgE和II型 (T2) 细胞因子 (如IL-5) 的治疗方法.
- 目前的治疗方法面临局限性,许多T2高喘患者没有反应,而T2低喘患者只有很少的选择.
- 在喘中,精准医学需要超越IgE和T2通路的新治疗点.
研究的目的:
- 审查当前对过敏呼吸道疾病中的警报生物学的理解.
- 将警示素的机制性见解与临床影响和药物开发联系起来.
- 突出已批准的,正在研究中的和潜在的未来的阿拉明向治疗方法.
主要方法:
- 关于警生物学的科学文献的综述 (胸膜层淋巴蛋白,IL-25,IL-33) 和它们的受体.
- 对机理学研究的分析,将警报信号与过敏呼吸道炎症中的先天和适应性免疫反应联系起来.
- 对临床数据和药物开发管道的检查,用于警报向治疗.
主要成果:
- 警示剂在免疫细胞上游起作用,影响先天性和适应性免疫.
- 向警示素显示出治疗T2高和T2低喘的潜力.
- 作为一种抗胸膜性 stromal lymphopoietin 抗体的 tezepelumab 已被批准用于治疗严重的喘.
结论:
- 报警器代表了针对喘和过敏性疾病的精密医学的新前沿.
- 向警示素为那些对现有的IgE或T2向疗法没有反应的患者提供治疗潜力.
- 对警报信号通路的进一步研究将推动开发新的喘治疗方法.
关键词:
报警器是一个警报器.这是一种IL-17RA.它们的IL-17RB.它们是IL-25和IL-25.这里有IL-33和IL-33.一个ILRLRL1在OX40L中.ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2 ST2在TLR4中,这是TSLP的TSLP.在TSLPR中使用.呼吸道炎症 呼吸道炎症过敏性气道疾病作为一个tegolimabb.基类动物的基.树突细胞是一种树突细胞.埃索诺菲尔细胞的存在皮质衍生的细胞因子.这就是Etokimab的意义.这是一个令人惊叹的故事.巨细胞 巨细胞泰泽佩卢姆巴姆的意思是形细胞是形细胞的细胞.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231